BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2683090)

  • 1. Therapeutic potential of non-heparin glycosaminoglycans of natural origin.
    Bianchini P
    Semin Thromb Hemost; 1989 Oct; 15(4):365-9. PubMed ID: 2683090
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-heparin glycosaminoglycan-derived drugs: a biochemical and pharmacologic perspective.
    Walenga JM; Hoppensteadt D; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 2():137-42. PubMed ID: 1835134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycans from Ateroid and bovine duodenal mucosa and pancreas.
    Seethanathan P; Dalferes E; Radhakrishnamurthy BS; Victor R; Berenson GS
    Mol Cell Biochem; 1975 Sep; 8(3):177-83. PubMed ID: 52831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulodexide: a renewed interest in this glycosaminoglycan.
    Lauver DA; Lucchesi BR
    Cardiovasc Drug Rev; 2006; 24(3-4):214-26. PubMed ID: 17214598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparin.
    Hoppensteadt D; Racanelli A; Walenga JM; Fareed J
    Semin Thromb Hemost; 1989 Oct; 15(4):378-85. PubMed ID: 2530633
    [No Abstract]   [Full Text] [Related]  

  • 7. Total glycosaminoglycan fraction from bovine aorta, intestinal mucosa & lungs on the concentration of lipids, plasma lipolytic activity & blood coagulation.
    Sherief PM; Sreekumar P; Sudhakaran PR; Kurup PA
    Indian J Exp Biol; 1978 Feb; 16(2):218-21. PubMed ID: 680816
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sulodexide in the therapy of vasculopathies].
    Postiglione F; Pisani P; Gisonni P; Perrotta P; Gisonni A; Canciello M; Napolitano L; Brighina G; Ragno I; Salzano A
    Clin Ter; 1986 May; 117(3):223-31. PubMed ID: 3524974
    [No Abstract]   [Full Text] [Related]  

  • 9. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin].
    Kurmukov AG; Aĭzikov MI; Rasulova SA; Makhmudov OKh
    Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of substances with antihypoxic action in experimental hyperlipidemia].
    Ryzhenkov VE; Remezova OV; Triufanov VF; Vasil'eva LE
    Eksp Klin Farmakol; 1992; 55(5):39-41. PubMed ID: 1305449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of obstetrical blood coagulation defects].
    Beller FK
    Zentralbl Gynakol; 1973 Aug; 95(32):1089-1100. PubMed ID: 4586914
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypolipidemic properties of triterpenoids].
    Vasilenko IuK; Lisevitskaia LI; Frolova LM; Parfent'eva EP; Skul'te IV
    Farmakol Toksikol; 1982; 45(5):66-70. PubMed ID: 7140959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines].
    Ryzhenkov VE; Chistiakova AM; Okunevich IV
    Patol Fiziol Eksp Ter; 1989; (5):16-9. PubMed ID: 2616207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional heterogeneity in dermatan sulfate preparations.
    Fareed J; Hoppensteadt D; Walenga JM; Ahsan A; Coyne E; Breddin HK
    Semin Thromb Hemost; 1991; 17 Suppl 2():174-80. PubMed ID: 1948088
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombin III-independent effect of depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice.
    Nagase H; Kitazato KT; Sasaki E; Hattori M; Kitazato K; Saito H
    Thromb Haemost; 1997 Feb; 77(2):399-402. PubMed ID: 9157603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithrombogenic action of a new extract: 3GS].
    Rusconi C; Orlando G
    Minerva Cardioangiol; 1975 Sep; 23(9):565-70. PubMed ID: 125860
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of a natural mucopolysaccharide-fibrinolytic complex on venous thrombosis and on the clearing factor].
    Pirani R; Pozzar C; De Lorenzi E
    Clin Ter; 1982 Mar; 100(6):575-96. PubMed ID: 6211330
    [No Abstract]   [Full Text] [Related]  

  • 20. [The hypolipidemic activity of natural substances].
    Okunevich IV; Kliueva NN; Solov'eva MA; Triufanov VF; Ryzhenkov VE
    Eksp Klin Farmakol; 1992; 55(5):44-7. PubMed ID: 1305452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.